Systematic review of the role of rituximab in treatment of antineutrophil cytoplasmic autoantibody-associated vasculitis, hepatitis C virus-related cryoglobulinemic vasculitis, Henoch–Schönlein purpura, ankylosing spondylitis, and Raynaud’s phenomenon

Rituximab (RTX) is established for the treatment of rheumatoid arthritis. This systematic review of the literature since 2006 summarizes evidence for the use of RTX in the treatment of additional rheumatological diseases: antineutrophil cytoplasmic autoantibody-associated vasculitis (AAV), hepatitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Taha, Rbab, El-Haddad, Hadeel, Almuallim, Abdulqader, Alshaiki, Fatma, Obaid, Elaf, Almoallim, Hani
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735990/
https://www.ncbi.nlm.nih.gov/pubmed/29290695
http://dx.doi.org/10.2147/OARRR.S149373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735990/
https://www.ncbi.nlm.nih.gov/pubmed/29290695
http://dx.doi.org/10.2147/OARRR.S149373

Ejemplares similares